Literature DB >> 8254720

Phenotypic characterization of insertion mutants of the human immunodeficiency virus type 1 Gag precursor expressed in recombinant baculovirus-infected cells.

N Chazal1, C Carrière, B Gay, P Boulanger.   

Abstract

A panel of 28 insertion mutants of the human immunodeficiency virus type 1 (HIV-1) Gag precursor (Pr55Gag) was constructed by linker-insertion mutagenesis and expressed in recombinant baculovirus-infected insect cells. One set of 14 mutants carried the normal N-myristylation signal; the other set constituted their non-N-myristylated counterparts. The mutants were characterized with respect to (i) assembly and extracellular release of membrane-enveloped budding Gag particles, (ii) intracellular assembly and nuclear transport of Gag cores, (iii) specific processing of Pr55Gag by HIV-1 protease in vivo, and (iv) binding of Pr55Gag to an HIV-1 genomic RNA probe in Northwestern blotting. Insertions within the region between amino acid residues 209 and 334 in the CA domain appeared to be the most detrimental to Gag particle assembly and release of Gag into the external medium, whereas a narrower window, between residues 209 and 241, was found to be critical for secretion of soluble Pr55Gag. Differences in Pr55Gag processing in vivo and RNA binding in vitro between N-myristylated and non-N-myristylated Gag mutants suggested a major conformational role for the myristylated N terminus of Gag precursor. In coinfection experiments using wild-type Gag- and mutant Gag-expressing recombinants, a transdominant negative effect on Gag particle assembly and release was observed for insertions located in two separate domains, the matrix and nucleocapsid.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8254720      PMCID: PMC236270     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release.

Authors:  H G Göttlinger; T Dorfman; J G Sodroski; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

2.  Binding of human immunodeficiency virus type 1 (HIV-1) RNA to recombinant HIV-1 gag polyprotein.

Authors:  J Luban; S P Goff
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

3.  Identification of global suppressors for temperature-sensitive folding mutations of the P22 tailspike protein.

Authors:  B Fane; R Villafane; A Mitraki; J King
Journal:  J Biol Chem       Date:  1991-06-25       Impact factor: 5.157

4.  RNA packaging signal of human immunodeficiency virus type 1.

Authors:  T Hayashi; T Shioda; Y Iwakura; H Shibuta
Journal:  Virology       Date:  1992-06       Impact factor: 3.616

5.  Expression and extracellular release of human immunodeficiency virus type 1 Gag precursors by recombinant baculovirus-infected cells.

Authors:  M Royer; S S Hong; B Gay; M Cerutti; P Boulanger
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

6.  A single amino acid substitution within the matrix protein of a type D retrovirus converts its morphogenesis to that of a type C retrovirus.

Authors:  S S Rhee; E Hunter
Journal:  Cell       Date:  1990-10-05       Impact factor: 41.582

7.  Location of epitopes on the major core protein p24 of human immunodeficiency virus.

Authors:  J P Langedijk; J J Schalken; M Tersmette; J G Huisman; R H Meloen
Journal:  J Gen Virol       Date:  1990-11       Impact factor: 3.891

8.  Autoprocessing of the human immunodeficiency virus type 1 protease precursor expressed in Escherichia coli from a synthetic gene.

Authors:  V Valverde; P Lemay; J M Masson; B Gay; P Boulanger
Journal:  J Gen Virol       Date:  1992-03       Impact factor: 3.891

9.  Expression of simian type D retroviral (Mason-Pfizer monkey virus) capsids in insect cells using recombinant baculovirus.

Authors:  M A Sommerfelt; C R Roberts; E Hunter
Journal:  Virology       Date:  1993-01       Impact factor: 3.616

10.  Amino acid substitutions within the matrix protein of type D retroviruses affect assembly, transport and membrane association of a capsid.

Authors:  S S Rhee; E Hunter
Journal:  EMBO J       Date:  1991-03       Impact factor: 11.598

View more
  39 in total

1.  Structural analysis of membrane-bound retrovirus capsid proteins.

Authors:  E Barklis; J McDermott; S Wilkens; E Schabtach; M F Schmid; S Fuller; S Karanjia; Z Love; R Jones; Y Rui; X Zhao; D Thompson
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

2.  A long terminal repeat-containing retrotransposon of Schizosaccharomyces pombe expresses a Gag-like protein that assembles into virus-like particles which mediate reverse transcription.

Authors:  Laure Teysset; Van-Dinh Dang; Min Kyung Kim; Henry L Levin
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

3.  Effects of Gag mutation and processing on retroviral dimeric RNA maturation.

Authors:  William Fu; Que Dang; Kunio Nagashima; Eric O Freed; Vinay K Pathak; Wei-Shau Hu
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

4.  Myristoylation is required for human immunodeficiency virus type 1 Gag-Gag multimerization in mammalian cells.

Authors:  Hua Li; Jun Dou; Lingmei Ding; Paul Spearman
Journal:  J Virol       Date:  2007-09-19       Impact factor: 5.103

5.  Detection of a trimeric human immunodeficiency virus type 1 Gag intermediate is dependent on sequences in the matrix protein, p17.

Authors:  Y Morikawa; W H Zhang; D J Hockley; M V Nermut; I M Jones
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

6.  Identification of retroviral late domains as determinants of particle size.

Authors:  L Garnier; L J Parent; B Rovinski; S X Cao; J W Wills
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

7.  HIV Gag-leucine zipper chimeras form ABCE1-containing intermediates and RNase-resistant immature capsids similar to those formed by wild-type HIV-1 Gag.

Authors:  Kevin C Klein; Jonathan C Reed; Motoko Tanaka; Veronica T Nguyen; Samina Giri; Jaisri R Lingappa
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

8.  Comparison of the NMR and X-ray structures of the HIV-1 matrix protein: evidence for conformational changes during viral assembly.

Authors:  M A Massiah; D Worthylake; A M Christensen; W I Sundquist; C P Hill; M F Summers
Journal:  Protein Sci       Date:  1996-12       Impact factor: 6.725

9.  p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease.

Authors:  M Huang; J M Orenstein; M A Martin; E O Freed
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

10.  In vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain.

Authors:  S Campbell; A Rein
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.